In their important study, Tsien et al 1 demonstrated for the first time that minor increases of serum creatinine have major clinical impact in outpatients with cirrhosis, ascites and normal serum creatinine. Patients with acute kidney injury (AKI) had a slow constant increase of serum creatinine over time and, interestingly, a reduced survival probability. These data support the concept that not only hepatorenal syndrome, but also minor changes of normal serum creatinine may have clinical importance. 2 3 However, no predictors of reversal of AKI could be identified. Possibly, more sensitive markers of reduced glomerular filtration rate, such as cystatin C 4 As the baseline serum creatinine increases, the discrepancy between the two definitions increases significantly.
